Patient-controlled epidural analgesia: a prospective audit of epidural pethidine 4 mg/ml and ropivacaine 0.2% with fentanyl 2 micrograms/ml.
A prospective audit of one hundred and forty-seven (147) Acute Pain Service (APS) patients, who received postoperative patient-controlled epidural analgesia (PCEA) using pethidine 4 mg/ml or ropivacaine 0.2% with fentanyl 2 micrograms/ml in general surgical or orthopaedic wards over a twelve-month period, is presented. Data were collected from APS observation charts over a 48-hour period postoperatively. We found no significant difference in postoperative analgesia or side-effects between pethidine and ropivacaine with fentanyl in orthopaedic or general surgical patients.
Tay
T G
TG
Pain Management Unit, Department of Anaesthesia, United Christian Hospital, Kwun Tong, Hong Kong.
Brake
T J
TJ
Kwan
A S
AS
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000577:Amides; D015360:Analgesia, Epidural; D016058:Analgesia, Patient-Controlled / Q000379:methods*; D000701:Analgesics, Opioid; D000779:Anesthetics, Local; D001794:Blood Pressure; D004338:Drug Combinations; D005260:Female; D005283:Fentanyl; D006801:Humans; D008297:Male; D008614:Meperidine; D008875:Middle Aged; D010149:Postoperative Pain / Q000188:drug therapy*; D011446:Prospective Studies; D012119:Respiration; D000077212:Ropivacaine
D000577:Amides; D000701:Analgesics, Opioid; D000779:Anesthetics, Local; D004338:Drug Combinations; D000077212:Ropivacaine; D008614:Meperidine; D005283:Fentanyl